Comparison of calcium sulfate and autogenous bone graft to bioabsorbable membranes plus autogenous bone graft in the treatment of intrabony periodontal defects: A split-mouth study
M. Orsini et al., Comparison of calcium sulfate and autogenous bone graft to bioabsorbable membranes plus autogenous bone graft in the treatment of intrabony periodontal defects: A split-mouth study, J PERIODONT, 72(3), 2001, pp. 296-302
Background: Current literature shows that calcium sulfate can be used in gu
ided tissue regeneration. Its biocompatibility and resorbability give it si
gnificant advantages in the treatment of periodontal and endodontic defects
. Clinically guided tissue regeneration procedures have demonstrated signif
icant positive clinical change, beyond that achieved with debridement alone
, in treating intraosseous defects. The aim of the present investigation wa
s to evaluate the clinical results obtained with autologous bone plus calci
um sulfate, and to compare them with the results obtained using autologous
bone plus membrane.
Methods: A total of 12 patients were treated in the present investigation.
A split-mouth design was utilized. Twelve 3-wall periodontal defects were t
reated with calcium sulfate plus autologous bone graft (test) and compared
with 12 contra-lateral defects treated with a bioabsorbable membrane plus a
utologous bone graft (control). Before the surgical procedure, patients wer
e instructed about oral hygiene and scaling and root planing (SRP) was comp
leted. Probing depth (PD), clinical attachment level (CAL), and bleeding on
probing (BOP) were recorded at baseline and 6 months.
Results: There were no statistical differences between test and control def
ects at baseline. BOP was 58% and 50% for control and test defects, respect
ively. Mean PD was 7.75 +/- 0.96 mm (control) and 8.0 +/- 1.28 mnn (test).
Mean CAL was 8.58 +/- 1.31 mm (control) and 8.83 +/- 0.91 mm (test). At 6 m
onths, mean PD was 3.41 +/- 0.51 (P= 0.0022) for control defects and 3.58 /- 0.51 (P= 0.0022) for test defects. CAL showed a mean gain of 5 +/- 0.85
for controls (P= 0.0022) and 5.25 +/- 0.75 for test defects (P= 0.0022), Th
us, there was a mean reduction of PD of 4.33 mm (56%) for control sites and
4.42 mm (55%) for test sites. The mean clinical attachment gain was 3.57 m
m for control sites and 3.58 mm for test sites. As there were no sham-opera
ted controls, it is not clear that the healing of these test or control-tre
ated sites was any better than similar 3-walled defects sham operated.
Conclusions: Both therapies led to short-term improvement of the measured p
arameters; neither was superior to the other.